Françoise Raffalli-Mathieu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Françoise Raffalli-Mathieu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Tina Glisovic
Division of Pharmaceutical Biochemistry, Uppsala Biomedical Centre, Uppsala University, Box 578, SE-751 23, Uppsala, Sweden
2 shared publicationsKyle Christian
1 shared publicationMalin Söderberg
1 shared publicationMatti A. Lang
Division of Biochemistry, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Biomedical Centrum, University of Uppsala, Sweden (F.R.-M., T.G., M.A.L.); and 2Department of Medical Biophysics, University of Toronto, Sunnybrook and Women's College Health Science Centre, Toronto, Ontario, Canada (Y.B.-D.).
1 shared publicationMatti Lang
1 shared publicationYaacov Ben-David
Division of Biochemistry, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Biomedical Centrum, University of Uppsala, Sweden (F.R.-M., T.G., M.A.L.); and 2Department of Medical Biophysics, University of Toronto, Sunnybrook and Women's College Health Science Centre, Toronto, Ontario, Canada (Y.B.-D.).
1 shared publication
Latest Publications
- 1 May 2003
- Published by Elsevier in Biochemical Pharmacology
- Vol. 65 (10) , 1653-1661
Interplay between transcriptional and post-transcriptional regulation of Cyp2a5 expression
- 1 May 2003
- Published by Elsevier in Biochemical Pharmacology
- Vol. 65 (10) , 1653-1661
Interplay between transcriptional and post-transcriptional regulation of Cyp2a5 expression
- 1 April 2002
- Published by Elsevier in Molecular Pharmacology
- Vol. 61 (4) , 795-799
Heterogeneous Nuclear Ribonucleoprotein A1 and Regulation of the Xenobiotic-Inducible GeneCyp2a5
The heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) functions in the packaging of nascent RNA polymerase II transcripts and participates in a variety of nuclear and cytoplasmic processes that modulate gene expression. The RNA binding characteristics of hnRNP A1 suggest that it can modulate the expression of specific genes, but little is known about its possible targets in vivo. In this article, we show that hnRNP A1 interacts with the transcript of a cytochrome P450 gene,Cyp2a5, induced by xenobiotics and during liver damage. Binding of the hnRNP A1 to CYP2A5 mRNA was demonstrated by immunoprecipitation of the xenobiotic-stimulated (37/39 kDa) CYP2A5 mRNA-protein complex with a monoclonal anti-hnRNP A1 antibody, by partial trypsin digestion of the complex, and by showing that the RNA-protein complex is not formed with protein extracts from cells lacking the hnRNP A1. We also show that a specific hepatotoxic inducer of the Cyp2a5 gene, pyrazole, increases the cytoplasmic levels of hnRNP A1 in vivo. Finally, we show that hnRNP A1 can be overexpressed in mouse primary hepatocytes, leading to an accumulation of the CYP2A5 mRNA. Collectively, these results indicate that the hnRNP A1 is an important regulator of the Cyp2a5 gene.
- 1 April 2002
- Published by Elsevier in Molecular Pharmacology
- Vol. 61 (4) , 795-799
Heterogeneous Nuclear Ribonucleoprotein A1 and Regulation of the Xenobiotic-Inducible GeneCyp2a5
The heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) functions in the packaging of nascent RNA polymerase II transcripts and participates in a variety of nuclear and cytoplasmic processes that modulate gene expression. The RNA binding characteristics of hnRNP A1 suggest that it can modulate the expression of specific genes, but little is known about its possible targets in vivo. In this article, we show that hnRNP A1 interacts with the transcript of a cytochrome P450 gene,Cyp2a5, induced by xenobiotics and during liver damage. Binding of the hnRNP A1 to CYP2A5 mRNA was demonstrated by immunoprecipitation of the xenobiotic-stimulated (37/39 kDa) CYP2A5 mRNA-protein complex with a monoclonal anti-hnRNP A1 antibody, by partial trypsin digestion of the complex, and by showing that the RNA-protein complex is not formed with protein extracts from cells lacking the hnRNP A1. We also show that a specific hepatotoxic inducer of the Cyp2a5 gene, pyrazole, increases the cytoplasmic levels of hnRNP A1 in vivo. Finally, we show that hnRNP A1 can be overexpressed in mouse primary hepatocytes, leading to an accumulation of the CYP2A5 mRNA. Collectively, these results indicate that the hnRNP A1 is an important regulator of the Cyp2a5 gene.